Teva Pharmaceutical Industries Limited
(NASDAQ:TEVA)|
41.35 -1.80 (-4.17%) Dec 01 - Close |
|
|
|
After-Hours 41.35 0.00 (0.00%) Mon, 1 Dec 2008 6:50 PM
- Compare TEVA with:
- View: Line | Candlestick
Company Profile
Teva Pharmaceutical Industries Limited
5 Basel Street
Petach Tikva, 49131
Israel - Map
Phone: 97239267267
Fax: 97239267472
Website: www.tevapharm.com
CEO: Shlomo Yanai
Employees: 27,900
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Mfr/mkt/dist pharmaceutical & veterinarian prods
A global pharmaceutical company, which develops, produces and markets generic drugs covering all major treatment categories.
Recent news for TEVA
-
Investopedia - 3 hours ago
-
Israel Stocks: Market lower; Bank Mizrachi is lauded by 2 analysts
MarketWatch - 7 hours ago
-
Israel Stocks: Tel Aviv shares higher on Teva, ICL, Elbit gains
MarketWatch - Yesterday at 11:19 ET
-
Market Strategies for the Very Brave
The Wall Street Journal Online - Yesterday at 10:47 ET
-
[$$] EU Blasts Drug Titans' Tactics
The Wall Street Journal Online - Nov 28 at 9:47 ET
-
[$$] EU Blasts Drug Titans' Tactics
The Wall Street Journal Online - Nov 28 at 6:58 ET
-
German health insurer AOK picks generics suppliers
Reuters - Nov 28 at 11:37 ET
-
From Patent Thickets to Payoffs: How Big Pharma Fights Generics
The Wall Street Journal Online - Nov 28 at 9:01 ET
-
AstraZeneca, Teva settle Pulmicort dispute
bizjournals.com - Nov 28 at 7:05 ET
-
UPDATE - EU accuses drugmakers of blocking cheaper generics
Reuters - Nov 28 at 5:53 ET